igf-2r (ABclonal Biotechnology)
Structured Review

Igf 2r, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/igf-2r/rabbit+anti+igf2r++1+500++a13022/pmc09827768-110-27-33
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "Neuroprotective effects of insulin-like growth factor-2 in 6-hydroxydopamine-induced cellular and mouse models of Parkinson’s disease"
Article Title: Neuroprotective effects of insulin-like growth factor-2 in 6-hydroxydopamine-induced cellular and mouse models of Parkinson’s disease
Journal: Neural Regeneration Research
doi: 10.4103/1673-5374.355815
Figure Legend Snippet: Changes in IGF-2 and IGF-2R expression in PD models. (A, B) In PD model mice, IGF-2 protein expression was reduced. (C, D) In SH-SY5Y cells, IGF-2 protein expression in the 6-OHDA group was reduced. (E, H) IGF-2R protein expression was also decreased in PD model mice. (F, I) Time-dependent immunoblotting study of the effect of 6-OHDA on IGF-2R expression in SH-SY5Y cells. (G, J) Effect of IGF-2 pretreatment on IGF-2R expression in SH-SY5Y cells subjected to 6-OHDA-induced injury. Western blot results showing the effect of different durations of IGF-2 pretreatment on IGF-2R expression 24 hours after 6-OHDA injury. All data are presented as mean ± SEM ( n ≥ 3).* P < 0.05, ** P < 0.01 (one-way analysis of variance followed by Tukey’s post hoc test). 6-OHDA: 6-Hydroxydopamine; IGF-2: insulin-like growth factor-2; IGF-2R: insulin-like growth factor-2 receptor; PD: Parkinson’s disease.
Techniques Used: Expressing, Western Blot
Related Articles
Expressing:Article Title: Neuroprotective effects of insulin-like growth factor-2 in 6-hydroxydopamine-induced cellular and mouse models of Parkinson’s disease Article Snippet: The following primary antibodies were used: β-actin (mouse, 1:1000, Cat# ab8226, RRID: AB_306371, Abcam, Cambridge Science Park, Cambridge, UK), Western Blot:Article Title: Neuroprotective effects of insulin-like growth factor-2 in 6-hydroxydopamine-induced cellular and mouse models of Parkinson’s disease Article Snippet: The following primary antibodies were used: β-actin (mouse, 1:1000, Cat# ab8226, RRID: AB_306371, Abcam, Cambridge Science Park, Cambridge, UK), |